is semaglutide and glp 1 the same thing GLP-1 as Ozempic? Understanding Key Differences semaglutide [TUSOM | Pharmwiki]

Safety Considerations and Future Outlook As with all pharmacotherapy for obesity and T2D, establishing cardiovascular safety and demonstrating improvements in meaningful clinical outcomes will be essential, particularly as cardiovascular outcome trials have not yet been completed with multi-agonists (although data are expected soon for tirzepatide: SURPASS-CVOT [T2D] in 2025

Zhang B, Cheng Z, Chen J, et al

The immunocompromised may have a hard time recovering, and have more frequent recurrences

For many people, non-GLP-1 medications, alone or in combination, can produce meaningful, sustainable results when chosen thoughtfully